Free Shipping on Orders over $200
Unlock 10% Off with Email Signup
Same-Day Shipping Before 3 PM EST
Dispatched Within 24 Hours
Referenced in Human Studies
Third-Party COA Verified
Sourced from Trusted Labs in EU
Scientific Advisory Oversight
Ipamorelin is a short peptide sequence capable of binding to the ghrelin/growth hormone secretagogue receptor. It is one of the most selective growth hormone (GH) secretagogues known and has been shown in laboratory studies to have no effect on ACTH, prolactin, follicle-stimulating hormone, luteinizing hormone, thyroid-stimulating hormone, or cortisol release [1]. Given its high level of specificity, ipamorelin has been of interest in research both as a therapeutic in and of itself as well as a model peptide for understanding how selectivity in GH receptor binding is achieved. Its presence plays a key role in the overall growth and repair of musculoskeletal tissue.
Our local team are here to help
Have more questions about peptide research? You’re not alone. Explore our Frequently Asked Questions for quick answers—or head to the Knowledge Base to explore study areas, calculators, and protocol guides.
Ipamorelin is studied for its ability to stimulate growth hormone release in a controlled and selective manner.
It’s known for having fewer off-target effects in preclinical GH stimulation research.
Yes, it’s often combined with CJC-1295 for dual-pathway studies.
One to three times daily use is typical depending on the study design.
Refrigerate after mixing and use within 30 days.
